Drug · DIN 02469774
ROCURONIUM BROMIDE INJECTION
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 5, 2026; first marketed January 17, 2019.
- Drug Identification Number (DIN)
- 02469774
- Company (DIN owner)
- Juno Pharma Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Rocuronium bromide M03AC09
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ROCURONIUM BROMIDE | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 5, 2026: NOC 37497Abbreviated New Drug Submission (ANDS) · Administrative: Merger/Buy-out
- May 5, 2020: NOC 23551Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- November 10, 2017: NOC 20035Abbreviated New Drug Submission (ANDS)
Other DINs named ROCURONIUM BROMIDE INJECTION
- DIN 02318415 · Marketed
- DIN 02517744 · Marketed
- DIN 02528657 · Marketed
- DIN 02529831 · Marketed
- DIN 02318121 · Cancelled Post Market
- DIN 02382415 · Cancelled Post Market
- DIN 02442752 · Approved